Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The impact of cell heterogeneity and immunophenotypic changes on monitoring minimal residual disease in acute myeloid leukemia.

Neoplasma - 1 Jan 2006

Zelezníková T, Babusíková O

Abstract excerpt

Monitoring of minimal residual disease (MRD) becomes increasingly important for the more accurate stratification of the therapy in acute leukemia. The purpose of this study was to characterize in detail the phenotypes of heterogeneous population in various AML subtypes and to identify the leukemia associated aberrant phenotype (LAP) in individual patients with AML for precise investigation of MRD. The impact of...

Topics

Acute Disease
Adolescent
Adult
Aged
Aged, 80 and over
Blast Crisis
Bone Marrow
Child
Child, Preschool
Female
Flow Cytometry
Humans

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Immunophenotyping

Leukemia, Myeloid

Leukocyte Common Antigens

Male

Middle Aged

Neoplasm Recurrence, Local

Source

Identifiers

PMID: 17167719

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The impact of cell heterogeneity and immunophenotypic changes on monitoring minimal residual disease in acute myeloid leukemia.PMID 17167719Read ↗

MINIMAL RESIDUAL DISEASE IN ACUTE MYELOID LEUKEMIA OF ADULTS: DETERMINATION, PROGNOSTIC IMPACT AND CLINICAL APPLICATIONS.Semantic proximity Read ↗

The role of multiparameter flow cytometry for detection of minimal residual disease in acute myeloid leukemia.Semantic proximity Read ↗

Immunological detection of blast cell subpopulations in acute myeloblastic leukemia at diagnosis: implications for minimal residual disease studies.Semantic proximity Read ↗

Tumor heterogeneity makes AML a “moving target” for detection of residual diseaseSemantic proximity Read ↗

Incidence, sensitivity, and specificity of leukemia-associated phenotypes in acute myeloid leukemia using specific five-color multiparameter flow cytometry.Semantic proximity Read ↗

Tumor heterogeneity makes AML a "moving target" for detection of residual disease.Semantic proximity Read ↗

Leukemia‐associated immunophenotypes subdivided in “categories of specificity” improve the sensitivity of minimal residual disease in predicting relapse in acute myeloid leukemiaSemantic proximity Read ↗

Identification of leukemia-associated immunophenotypes by database-guided flow cytometry provides a highly sensitive and reproducible strategy for the study of measurable residual disease in acute myeloblastic leukemiaSemantic proximity Read ↗

Defining minimal residual disease in acute myeloid leukemia: which platforms are ready for “prime time”?Semantic proximity Read ↗

Characterization of aberrant phenotypes in acute myeloblastic leukemia.Semantic proximity Read ↗

Minimal residual disease and stem cell transplantation outcomes.Semantic proximity Read ↗

Stability of leukemia‐associated aberrant immunophenotypes in patients with acute myeloid leukemia between diagnosis and relapse: Comparison with cytomorphologic, cytogenetic, and molecular genetic findingsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.